Equities

Merit Medical Systems Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Merit Medical Systems Inc

Actions
  • Price (EUR)67.00
  • Today's Change-0.50 / -0.74%
  • Shares traded161.00
  • 1 Year change-35.58%
  • Beta0.6109
Data delayed at least 15 minutes, as of Feb 10 2026 07:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.

  • Revenue in USD (TTM)1.48bn
  • Net income in USD118.43m
  • Incorporated1987
  • Employees7.40k
  • Location
    Merit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttps://www.merit.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MMSI:NSQ since
announced
Transaction
value
Biolife LLCDeal completed20 May 202520 May 2025Deal completed-17.60%120.00m
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.